Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trialEugenio Mercuri, Katie Groves, Odile Boespflug‐Tanguy et al.|The Lancet Neurology|2021Cited by 260
Associations between appetite, physical activity and sedentary behaviour from hip‐ and <scp>wrist‐worn</scp> accelerometers in <scp>community‐dwelling</scp> older adultsLi‐Tang Tsai, Paolo Caserotti, Sussi Friis Buhl et al.|Geriatrics and gerontology international/Geriatrics & gerontology international|2023Cited by 6